StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Raymond James looks for further durability in BMY's (BMY) MountainTAP-30 trial
March 16, 2026 4:28 PM
Raymond James analyst Sean McCutcheon reiterated a Market Perform rating on Bristol-Myers Squibb Co. (NYSE: BMY)The analyst commented, "Monday, at ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments